Trial Profile
Impact of Inhibition of Thrombocyte Activation on the course of chronic Hepatitis C.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 31 Oct 2011
Price :
$35
*
At a glance
- Drugs Aspirin (Primary) ; Cilostazol (Primary) ; Clopidogrel (Primary) ; Dabigatran etexilate (Primary)
- Indications Embolism and thrombosis; Hepatitis C
- Focus Therapeutic Use
- 08 Aug 2011 New trial record